Ohio residents may be interested to learn that while the Food and Drug Administration (FDA) oversees all pharmaceutical drugs produced and distributed in the United States, it appears that the FDA and international organizations are finding law enforcement more difficult in cyberspace. As buyers seek out cheaper alternatives to purchasing medication in drug stores and pharmacies around the nation, online pharmacies are increasing their presence to take advantage of the available consumer base.
Interest groups were putting pressure on the White House to compete its final safety review on medical device identifiers. Premier healthcare alliance, which represents purchasers of devices, and The Pew Charitable Trusts, a research organization, were asking the White House Office of Management and Budget, or OMB, to make a final decision concerning the Food and Drug Administration rule. The groups claim that the FDA missed a statutory deadline; they insist that the decision is necessary in order to provide safety and quality improvements regarding patient care in Ohio and all over the United States.
Ohio residents may be interested in a recent turn of events for two widows of coal miners. Their spouses' deaths were related to toxic materials breathed in during coal mining work. These men were never compensated during their lifetimes. However, a change due to the enactment of the Patient Protection and Affordable Care Act has brought a 1978 provision for dependent compensation back into effect. The Black Lung Benefits Act was amended then to provide benefits for the surviving family members of miners who died from pneumoconiosis. The provision was removed in 1981, but new hope for survivors is possible based on this case.
Ohio attorneys and patients are taking notice of a recent ruling by the Supreme Court stating that patients cannot sue generic drug makers for design defects, further limiting avenues of recovery for injured patients. Reversing an earlier state court's decision awarding $21 million to a victim injured by a generic medication, the ruling states that generic drug manufacturers are not liable for design defects because federal law requires them to replicate the brand name drug.